Research & Development
Teva awarded FDA approval for AJOVY (fremanezumab-vfrm) Injection Autoinjector for migraine treatment
29 January 2020 - Teva Pharmaceuticals USA Inc reported on Tuesday the receipt of approval from the Food and Drug Administration (FDA) for an autoinjector device for AJOVY (fremanezumab-vfrm) injectio...
Genprex Inc raises USD8m from at-the-market common stock offering
29 January 2020 - Gene therapy company Genprex Inc (NASDAQ:GNPX) revealed on Tuesday the completion of the sale of an aggregate of 7,620,000 shares of its common stock.The company issued the common st...
Blueberry Therapeutics passes FDA clearance to start clinical investigation of BB2603 for onychomycosis
28 January 2020 - Drug company Blueberry Therapeutics reported on Tuesday the receipt of the investigational new drug (IND) clearance from the Food and Drug Administration (FDA) to initiate the clinic...
US FDA approves Trijardy XR
28 January 2020 - The United States Food and Drug Administration (FDA) has approved Trijardy XR (empagliflozin/linagliptin/metformin hydrochloride extended release tablets) to decrease blood sugar in ...
Moderna Receives Funding Award from CEPI to Accelerate Development of Messenger RNA Vaccine Against Novel Coronavirus
27 January 2020 - - US-based clinical stage biotechnology company Moderna, Inc., (NASDAQ: MRNA) has forged a new collaboration to develop an mRNA vaccine against the novel coronavirus (2019-nCoV), the...
Ipsen's Palovarotene Clinical Programme in Fibrodysplasia Ossificans Progressiva Reaches Prespecified Interim Analysis Futility Criteria
27 January 2020 - - French pharmaceutical company Ipsen (Euronext: IPN) (OTC: IPSEY) has decided to pause dosing patients in the global Phase III (PVO-1A-301) study designed to evaluate the efficacy a...